ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

25,970Medicare Part D Prescriptions Filled, Including Refills

Rank: 10 out of 890

$1.11M Total Retail Price of All Prescriptions

Rank: 35 out of 890

644 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
54% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 644 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

20% of this provider’s 644 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

3% of this provider’s 22,456 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$43 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

40 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
LEVOTHYROXINE SODIUM 1,500 1,308 1 2
HYDROCODONE-ACETAMINOPHEN 703 553 S3 2 3
POTASSIUM CHLORIDE 683 604 3 11
FUROSEMIDE 667 580 4 7
LISINOPRIL 665 573 5 4
AMLODIPINE BESYLATE 573 516 6 1
GABAPENTIN 530 458 7 12
MELOXICAM 458 371 8 18
PRAVASTATIN SODIUM 454 405 9 10
OMEPRAZOLE 443 364 10 8
NEXIUM 416 394 11 14
SIMVASTATIN 401 369 12 5
CITALOPRAM HBR 399 331 13 20
GLIMEPIRIDE 375 303 14 27
METFORMIN HCL 358 301 15 6
WARFARIN SODIUM 344 340 16 24
ALLOPURINOL 311 271 17 31
ATORVASTATIN CALCIUM 284 234 18 13
CLONIDINE HCL 280 261 19 35
METOPROLOL TARTRATE 269 246 20 15
CARVEDILOL 265 230 21 22
ZOLPIDEM TARTRATE 264 204 22 19
DIOVAN 261 222 23 33
METFORMIN HCL ER 246 194 24 54
TAMSULOSIN HCL 245 241 25 32
ATENOLOL 241 169 26 23
LOSARTAN POTASSIUM 239 224 27 29
FLUTICASONE PROPIONATE 238 227 28 39
ISOSORBIDE MONONITRATE ER 234 219 29 60
HYDROCHLOROTHIAZIDE 233 176 30 9
TRAZODONE HCL 214 172 31 40
DONEPEZIL HCL 210 189 32 30
LANTUS 205 148 33 50
METOPROLOL SUCCINATE 199 191 34 17
PANTOPRAZOLE SODIUM 199 158 34 34
DILTIAZEM ER 197 177 36 129
SERTRALINE HCL 197 181 36 26
CLOPIDOGREL 193 157 38 28
POLYETHYLENE GLYCOL 3350 191 183 39 67
PREDNISONE 178 162 40 47
TRAMADOL HCL 177 140 41 16
MUPIROCIN 177 146 41 121
NAMENDA 174 174 43 36
ALENDRONATE SODIUM 172 172 44 38
GLIPIZIDE 163 139 45 62
TORSEMIDE 152 139 46 159
SULFAMETHOXAZOLE-TRIMETHOPRIM 149 120 47 76
BENAZEPRIL HCL 148 118 48 44
DIGOXIN 144 144 49 65
ROPINIROLE HCL 142 131 50 93
PLAVIX 136 114 51 42
AMITRIPTYLINE HCL 133 121 R 52 43
DOXYCYCLINE HYCLATE 129 108 53 89
LISINOPRIL-HYDROCHLOROTHIAZIDE 128 109 54 21
JANUVIA 123 94 55 59
SINGULAIR 119 99 56 79
PAROXETINE HCL 116 92 57 68
CYCLOBENZAPRINE HCL 116 82 R 57 64
MECLIZINE HCL 114 114 59 97
RANITIDINE HCL 109 89 60 49
AZITHROMYCIN 109 95 60 37
HYDRALAZINE HCL 107 100 62 100
METOCLOPRAMIDE HCL 106 90 63 125
DILTIAZEM 24HR ER 104 89 64 149
PREMARIN 104 102 R 64 105
ENABLEX 104 92 64 248
KLOR-CON 8 102 101 67 268
RISPERIDONE 100 82 68 78
CELEBREX 99 95 69 91
LIPITOR 98 89 70 77
PROAIR HFA 91 58 71 55
ADVAIR DISKUS 90 82 72 52
MEGESTROL ACETATE 90 90 R 72 92
FENTANYL 90 80 S2 72 151
RAMIPRIL 89 89 75 80
ESTRADIOL 87 77 R 76 118
GALANTAMINE HBR 86 86 77 349
FAMOTIDINE 84 70 78 90
FINASTERIDE 83 83 79 108
CRESTOR 83 77 79 25
NABUMETONE 81 81 81 143
LYRICA 81 50 81 71
SUCRALFATE 79 77 83 158
VERAPAMIL ER 79 67 83 87
TEKTURNA 75 75 85 247
DILTIAZEM 24HR CD 74 73 86 156
CIPROFLOXACIN HCL 74 70 86 58
AMLODIPINE BESYLATE-BENAZEPRIL 72 59 88 41
SPIRONOLACTONE 70 63 89 85
DIOVAN HCT 69 67 90 48
IPRATROPIUM BROMIDE 68 60 91 249
ESCITALOPRAM OXALATE 68 67 91 51
NIFEDIPINE ER 68 68 91 75
ACETAMINOPHEN-CODEINE 66 66 S3 94 124
GEMFIBROZIL 65 39 95 103
FOSINOPRIL SODIUM 64 52 96 184
NYSTATIN 64 63 96 173
TRAMADOL HCL-ACETAMINOPHEN 62 58 98 117
ZETIA 61 54 99 81
CARISOPRODOL 61 15 R 99 69
DOXAZOSIN MESYLATE 60 56 101 70
PROPRANOLOL HCL 60 53 101 141
ZOSTAVAX 60 54 101 233
DOXEPIN HCL 59 59 104 176
DEXILANT 59 59 104 138
FLUCONAZOLE 58 56 106 155
GLYBURIDE 57 46 R 107 83
BETAMETHASONE VALERATE 57 48 107 281
BISOPROLOL FUMARATE 57 52 107 163
MONTELUKAST SODIUM 57 49 107 130
PENTOXIFYLLINE 56 56 111 351
PHENYTOIN SODIUM EXTENDED 56 34 111 111
METHYLPREDNISOLONE 54 52 113 109
BUSPIRONE HCL 54 54 113 133
QUETIAPINE FUMARATE 53 53 115 73
KLOR-CON M20 52 35 116 72
LOVAZA 51 16 117 120
NYSTATIN-TRIAMCINOLONE 51 50 117 277
ENALAPRIL MALEATE 50 50 119 56
THEOPHYLLINE ANHYDROUS 50 27 119 243
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 14, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.